Grant: CIHR Fellowship
Université de Montréal
$90,000.00
Nanophotonics silencing of nociceptors-ILC2 crosstalk in AD-mediated skin inflammation
EF 2022-23
Résumé
Selective silencing of neuronal activity is a powerful approach for studying the roles of neuronal subpopulations in inflammatory diseases. Conventional pharmacological neuronal silencing strategies remain largely non-specific. Nanophotonics is a field that focuses on light-nanomaterials interactions. Shining light onto nanosized particles (1-100 nm) allows them to convert light to heat with exceptional efficiency, a feature that has been exploited for killing cancer cells1 and for neuromodulation2,3. During my postdoc I showed that this concept can be used to "block" (i.e., inhibit neuropeptide release and neuronal activity) individual sensory neurons by exploiting their heat responsive channels as controlled drug entry-ports4. This is a disruptive method to probe and/or control neuronal communication with other cell types without the need for genetic engineering.
My goal is to further investigate the specificity and in-vivo applicability of this approach as well as its therapeutic potential. This new technology for neuronal blockage can have a broad impact on neuroscience as it can help to elucidate the role of nociceptors in autoimmune pathologies such as atopic dermatitis (AD).
Compared to conventional drug delivery approaches, this interdisciplinary approach can enable single-cell specificity, long-lasting activity, and limited side-effects. If successful, the outcome of the project can become a new treatment for pain and inflammation.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
473912
Name
Roversi Katiane
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Nanophotonics silencing of nociceptors-ILC2 crosstalk in AD-mediated skin inflammation
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Atopic Dermatitis; Gold Nanoparticles; Nanophotonics; Neuroimmune Diseases; Nociceptors; Pain; Trpv1 Channel
Abstract
Selective silencing of neuronal activity is a powerful approach for studying the roles of neuronal subpopulations in inflammatory diseases. Conventional pharmacological neuronal silencing strategies remain largely non-specific. Nanophotonics is a field that focuses on light-nanomaterials interactions. Shining light onto nanosized particles (1-100 nm) allows them to convert light to heat with exceptional efficiency, a feature that has been exploited for killing cancer cells1 and for neuromodulation2,3. During my postdoc I showed that this concept can be used to "block" (i.e., inhibit neuropeptide release and neuronal activity) individual sensory neurons by exploiting their heat responsive channels as controlled drug entry-ports4. This is a disruptive method to probe and/or control neuronal communication with other cell types without the need for genetic engineering.
My goal is to further investigate the specificity and in-vivo applicability of this approach as well as its therapeutic potential. This new technology for neuronal blockage can have a broad impact on neuroscience as it can help to elucidate the role of nociceptors in autoimmune pathologies such as atopic dermatitis (AD).
Compared to conventional drug delivery approaches, this interdisciplinary approach can enable single-cell specificity, long-lasting activity, and limited side-effects. If successful, the outcome of the project can become a new treatment for pain and inflammation.
Competitiondate
202210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Roversi, Katiane
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~